Discover 2,367 paid clinical trials in Plainfield, Illinois. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Plainfield offers many clinical trial opportunities with focuses on various conditions, including ADHD, prurigo nodularis, autoimmune diseases like lupus, and cardiovascular conditions. The city's leading institutions are actively recruiting both healthy volunteers interested in paid research options, as well as those with specific health conditions for studies that could lead to groundbreaking discoveries and improved treatments.
Filter
2
Filter results
Results: 2,367
Prophylactic Conjoint Tendon Lengthening During Reverse Shoulder Arthroplasty Outcomes
for
Osteoarthritis Shoulder
Location: Maywood IL
Sponsor: Nickolas Garbis
Sex: All
Age: 18+
Code: NCT06729983
Recruiting
Comparing Magnesium 2g Versus 4g Versus Placebo in the Incidence of Treating AFF RVR
for
Tachycardia Atrial, Atrial Fibrillation,
Location: Oak Lawn IL
Sponsor: Wake Forest University Health Sciences
Sex: All
Age: 18+
Code: NCT06376916
Phase3, Recruiting
Effectiveness of Magnesium in Addition to Prochlorperazine for the Treatment of Migraines
for
Migraine
Location: Oak Lawn IL
Sponsor: Wake Forest University Health Sciences
Sex: All
Age: 18+
Code: NCT06904287
Phase3, Recruiting
Study to Reinforce Immunity (STRI) Phase 2 Clinical Trial
for
Covid19
Location: Oak Forest IL, Houston TX, Tampa FL, Doral FL,
Sponsor: Eyecheck, Inc.
Sex: All
Age: 18+
Code: NCT05046561
Phase2, Recruiting
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
for
Breast Cancer
Location: Oak Lawn IL, Elk Grove Village IL, Hoffman Estates IL,
Sponsor: Agendia
Sex: All
Age: 18+
Code: NCT03053193
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Vidaza and Valproic Acid Post Allogeneic Transplant for High Risk AML and MDS
Location: Chicago IL, Milwaukee WI, Indianapolis IN,
Sponsor: BrioHealth Solutions, Inc.
Sex: All
Age: 18 - 70+
Code: NCT06310031
Recruiting
DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
for
Medulloblastoma
Location: Chicago IL, St Louis MO, Louisville KY, Lexington KY,
Sponsor: Giselle Sholler
Sex: All
Age: 0 - 21
Code: NCT04696029
Phase2, Recruiting
Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System
for
Persistent Atrial Fibrillation
Location: Oak Lawn IL, Cincinnati OH, Royal Oak MI, Columbus OH,
Sponsor: Boston Scientific Corporation
Sex: All
Age: 18+
Code: NCT06735534
Recruiting
Initial Feasibility Study to Treat Borderline Resectable Pancreatic Cancer With a Planar LDR Source
for
Pancreatic Cancer
Location: Oak Lawn IL
Sponsor: CivaTech Oncology
Sex: All
Age: 18+
Code: NCT02843945
Phase1, Phase2, Recruiting
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
for
Chronic Kidney Disease and Hypertension
Location: Maywood IL, Rockford IL, Saint Joseph MI, Champaign IL,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06742723
Phase3, Recruiting
Evaluation Montelukast in the Treatment of Status Asthmaticus
for
Status Asthmaticus
Location: Oak Lawn IL
Sponsor: Corrie Fletcher
Sex: All
Age: 2 - 14
Code: NCT01770899
Recruiting
National Collaborative to Improve Care of Children With Complex Congenital Heart Disease
for
Hypoplastic Left Heart Syndrome (HLHS)
Location: Oak Lawn IL, Chicago IL, Milwaukee WI, Madison WI,
Sponsor: Children's Hospital Medical Center, Cincinnati
Sex: All
Age: 0 - 1
Code: NCT02852031
Recruiting
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
for
Stage I Mixed Cell Type Kidney Wilms Tumor,
Location: Oak Lawn IL, Chicago IL, Park Ridge IL, Peoria IL,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 30
Code: NCT06401330
Phase3, Recruiting
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)